NSE is an enzyme released during neuronal cell necrosis or apoptosis, serving as a biomarker to stratify illness severity and predict outcomes in various conditions, including sepsis-associated encephalopathy (SAE) [1], status epilepticus (SE) [2], and out-of-hospital cardiac arrest (OHCA) [3]. This evidence concerns the gene ENO2 and status epilepticus.